Stavanger University Hospital Inflammatory Bowel Disease Trial

Recruiting now

Conditions studied: IBD

In brief

The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.

Key facts

Study ID

NCT01551563

Run by

Helse Stavanger HF

People needed

700

Starts

2012-04-01

Expected to finish

2030-12-01

Last updated by the study team

2025-05-16

Who can join

Age: 16 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• newly diagnosed IBD

You may not qualify if…

• previous IBD with specific treatment within 10 year
• inability to consent
• inability to adhere to treatment protocol

Where it is running

• SUS — Stavanger, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.